HeyJaredActive Ingredients
The Active Ingredients podcast dissects the very essence of exceptional leadership in the life sciences.
- Indexed episodes, last 90 days
- 6
- Latest publication
- Sep 14, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 6, 2026
Latest episodes
Behind Glass: What Cdmo Leadership Really Demands With Joerg Ahlgrimm (opens the original)
Read excerpt
In this episode of the Active Ingredients podcast, host Thomas Dove interviews Joerg Ahlgrimm, Chief Executive Officer (CEO) of SK Pharmteco. Joerg Ahlgrimm has led global manufacturing networks at Baxter and Lonza, founded the gene therapy contract development and manufacturing organisation (CDMO) Centre for Breakthrough Medicines during COVID, and now leads SK Pharmteco’s global operations from the United States. In this conversation, he explains why listening, strategy, and fast decision-maki
What You Know, Who You Know and How You're Known with John Tomtishen (opens the original)
Read excerpt
In this episode of the Active Ingredients podcast , host Thomas Dove interviews John Tomtishen, Cell and Gene Therapy Executive Leader and Recognised CMC Expert John Tomtishen has spent over a decade in cell and gene therapy, helping deliver the first approved CAR-T therapy at Novartis, building the CMC strategy behind Legend Biotech's Carvykti, and now leading global field application and strategic alliances at Catalent. In this conversation, he shares the three principles- authenticity, integr
Building Win-Win Deals in Generics With Anish Mehta (opens the original)
Read excerpt
In this episode of the Active Ingredients podcast, host Thomas Dove speaks with Anish Mehta, Chief Executive Officer (CEO) of Synthon. Anish Mehta is a global pharmaceutical CEO whose career spans engineering, strategy consulting, commercial leadership, mergers and acquisitions (M&A), and private equity-backed transformation. From biomedical and chemical engineering to McKinsey, Baxter and Hospira, he has spent more than 25 years building businesses and creating value across innovative pharma an
Courage, Reinvention & Talent Development in Life Sciences with Michaela Griggs (opens the original)
Read excerpt
In this episode of the Active Ingredients podcast, host Thomas Dove interviews Michaela Griggs, Chief Executive Officer (CEO) at Ansella Therapeutics. Michaela Griggs is a turnaround CEO and board director whose career has encompassed global commercial leadership at Bayer and Allergan, CEO positions, and board appointments across healthcare, fertility, aesthetics, and biotech. In this conversation, she talks about what drives her to take on challenges others avoid, how a dyslexia diagnosis fuell
Bridging Commercial & Operations in CDMO with Michael Stanek (opens the original)
Read excerpt
In this episode of the Active Ingredients podcast, host Thomas Dove speaks with Michael Stanek, former Vice President (VP) and General Manager (GM) API Global at Thermo Fisher Scientific. With more than 25 years in the contract development and manufacturing (CDMO) sector, Michael has led turnarounds, integrated acquisitions and rethought how commercial and operational teams work together. He shares his dual sales model and what it takes to shift a big pharma culture into a multi-customer CDMO mi
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.